Clinical trial

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

NCT00020176

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention filgrastim Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention therapeutic allogeneic lymphocytes Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclosporine Normalized identity: cyclosporineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record fludarabine phosphate Normalized identity: fludarabine phosphateView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention peripheral blood stem cell transplantation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-06-01

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

filgrastimBIOLOGICAL

therapeutic allogeneic lymphocytesBIOLOGICAL

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

cyclosporineDRUG · verified · RxNorm: cyclosporine

fludarabine phosphateDRUG · verified · RxNorm: fludarabine phosphate

peripheral blood stem cell transplantationPROCEDURE

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00020176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.